KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

QuidelOrtho (QDEL) Capital Expenditures (2021 - 2025)

Historic Capital Expenditures for QuidelOrtho (QDEL) over the last 5 years, with Q3 2025 value amounting to $49.2 million.

  • QuidelOrtho's Capital Expenditures rose 580.65% to $49.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $190.1 million, marking a year-over-year decrease of 325.7%. This contributed to the annual value of $195.1 million for FY2024, which is 678.45% down from last year.
  • QuidelOrtho's Capital Expenditures amounted to $49.2 million in Q3 2025, which was up 580.65% from $37.5 million recorded in Q2 2025.
  • Over the past 5 years, QuidelOrtho's Capital Expenditures peaked at $106.9 million during Q4 2021, and registered a low of -$119.5 million during Q1 2023.
  • Over the past 5 years, QuidelOrtho's median Capital Expenditures value was $47.9 million (recorded in 2023), while the average stood at $39.8 million.
  • Per our database at Business Quant, QuidelOrtho's Capital Expenditures soared by 19333.33% in 2023 and then plummeted by 3118.91% in 2024.
  • Quarter analysis of 5 years shows QuidelOrtho's Capital Expenditures stood at $106.9 million in 2021, then tumbled by 78.95% to $22.5 million in 2022, then soared by 116.0% to $48.6 million in 2023, then fell by 2.88% to $47.2 million in 2024, then increased by 4.24% to $49.2 million in 2025.
  • Its Capital Expenditures was $49.2 million in Q3 2025, compared to $37.5 million in Q2 2025 and $56.2 million in Q1 2025.